相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial
Faustino Torrico et al.
LANCET INFECTIOUS DISEASES (2021)
Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole
James A. Watson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment
E. Aldasoro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial
Victor Kande Betu Ku Mesu et al.
LANCET (2018)
A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform
Maria-Jesus Pinazo et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Recent Updates on Development of Drug Molecules for Human African Trypanosomiasis
Ajmer Singh Grewal et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Tolerance of Benznidazole in a United States Chagas Disease Clinic
David A. Miller et al.
CLINICAL INFECTIOUS DISEASES (2015)
Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients
Juan Carlos Ramirez et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy
C. A. Morillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
Maria T. Bahia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies
Antoine Tarral et al.
CLINICAL PHARMACOKINETICS (2014)
Benznidazole-Related Adverse Drug Reactions and Their Relationship to Serum Drug Concentrations in Patients with Chronic Chagas Disease
Maria-Jesus Pinazo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Global economic burden of Chagas disease: a computational simulation model
Bruce Y. Lee et al.
LANCET INFECTIOUS DISEASES (2013)
` Severe Hepatotoxicity as a Result of Extended Use of Ornidazole
Yusuf Coskun et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Genotoxicity profile of fexinidazole-a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)
David Tweats et al.
MUTAGENESIS (2012)
Fexinidazole: A Potential New Drug Candidate for Chagas Disease
Maria Terezinha Bahia et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Trypanosoma cruzi and Chagas' Disease in the United States
Caryn Bern et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients
Alejandro G. Schijman et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease
Yves Jackson et al.
CLINICAL INFECTIOUS DISEASES (2010)
Fexinidazole - A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness
Els Torreele et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease Patients
Tomas Duffy et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
A critical review on Chagas disease chemotherapy
JR Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
分享论文
